Respiratory Medicine
Volume 101, Issue 10 , Pages 2168-2175 , October 2007

Differences in the etiology of community-acquired pneumonia according to site of care: A population-based study

  • Jordi Almirall

      Affiliations

    • Critical Care Unit, Hospital de Mataró, Universitat Autònoma de Barcelona, Mataró, Barcelona, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34937417700; fax: +34937417770.
    • ,
  • Ramon Boixeda

      Affiliations

    • Department of Internal Medicine, Hospital de Mataró, Mataró, Barcelona, Spain
    • ,
  • Ignasi Bolíbar

      Affiliations

    • Department of Clinical Epidemiology and Public Health, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
    • ,
  • Josep Bassa

      Affiliations

    • Emergency Department, Hospital de Mataró, Mataró, Barcelona, Spain
    • ,
  • Goretti Sauca

      Affiliations

    • Department of Clinical Microbiology, Hospital de Mataró, Mataró, Barcelona, Spain
    • ,
  • Josep Vidal

      Affiliations

    • Department of Clinical Microbiology, Hospital Clínic, Barcelona, Spain
    • ,
  • Mateu Serra-Prat

      Affiliations

    • Epidemiology Department, Hospital de Mataró, Mataró, Barcelona, Spain
    • ,
  • Xavier Balanzó

      Affiliations

    • Critical Care Unit, Hospital de Mataró, Universitat Autònoma de Barcelona, Mataró, Barcelona, Spain
    • ,
  • for the GEMPAC Study Group

      Affiliations

    • Participants in the GEMPAC Study Group. Primary Care Centres: J.M. de Salas, J. Costa, M. Tristany, M. J. Grau, S. Sancho, E. Miguel, M. Fradera, I. Ochoa and A. Quilez, M.J. Castany, Health Basic Area of Arenys (Institut Català de la Salut, ICS); V. Marina, P. Subias, B. Jimeno, A. Bradnovich, M. Rodriguez, E. Ramon, A. Gardella and C. Ginés, Health Basic Area of Canet de Mar and Sant Pol de Mar (ICS); J.C. Montero, P. Flores, P. Serra, E. Torrellas, I. Buxadé, J. Mussoll and M. Gomez, Health Basic Area of Cirera Molins (Consorci Sanitari del Maresme); X. Mestres, A. Armada, J. Mallafré, M. Roger, M.T. Gros, and N. Les, Health Basic Area of Ronda Cerdanya (ICS); J. Joanola, J. Doménech, M. Bundó, Mª Trilla, J. Massons, J. Montero, and E. Zurilla, Health Basic Area of Ronda Prim (ICS); M. Alegre, M. Papiol, O. Martí, M. Catalá, MA Martinez, A Casanovas and E. Diaz, Health Basic Area of Argentona (Consorci Sanitari del Maresme); P. Torán, M.M. Aizpurua, G. Lozano, J. Casals, J. Sorribes and D. Torrellas, Health Basic Area of Gatassa (ICS); A. Casas, J. Bernad, A. de Montoliu, J. Gaya, R. Vallés, A. Vazquez, R. Peiró, G. Aresté, GN. Mengual and M.C. Viñes, Health Basic Area of Vilassar de Mar (ICS); E. Almerich, M.A. Lopez, J. Bel, A. Gosalves, S. Macip, E. Carrillo, P. Paulo, M. Pol, J. Sala and P. Mir, Health Basic Area of Pineda (ICS); J. LL. Anglada, J. Salabarnada, E. Sanz, F. Gorgas, A. Ribas, E. Fau, I. Pellicer and S. Morales, Health Basic Area of Riera, Mataró (ICS ); E. Burdoy, LL. Busquets, S. de Castro, M. Bartolomé, E. Corona, R. Valverde and Y. Verde, Health Basic Area of Mataró Centre, Mataró (Consorci Sanitari del Maresme); A. Borrás and F. Aznar (Centre Mèdic de Mataró, Mataró); and F. Riera, A. Vazquez and P. Gil (GEMA S. L., Mataró). Hospital Centres: O. Parra, Hospital del Sagrat Cor, (Barcelona); F. Riera, Hospital de Barcelona (Barcelona); P. Tudela, Hospital Universitari Germans Trias i Pujol (Badalona); R. Tarradas and M. Berrocal, Hospital Sant Jaume (Calella); and J. Bigas, E. Coma, M. Daza, F. Casarramona, Hospital de Mataró (Barcelona).

Received 28 August 2006 ,Accepted 7 May 2007.

References 

  1. Honeybourne D. Community-acquired pneumonia in ambulatory patients: relative importance of atypical pathogens. Int J Antimicrob Agents. 2001;18(Suppl. 1):S57–S61
  2. Cunha BA. Ambulatory community-acquired pneumonia: the predominance of atypical pathogens. Eur J Clin Microbiol Infect Dis. 2003;22:579–583
  3. Almirall J, Casado M, Valls F, et al. Prospective study of community-acquired pneumonias seen in a general hospital. Diagnostic errors. Med Clin (Barc). 1991;97:250–254
  4. Almirall J, Morató I, Riera F, et al. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study. Eur Respir J. 1993;6:14–18
  5. Almirall J, Bolíbar I, Vidal J, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. Eur Respir J. 2000;15:757–763
  6. Fine MJ, Smith DN, Singer DE. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med. 1990;89:713–721
  7. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–250
  8. Ewig S, Schlocchtermeier M, Göke N, Niederman MS. Applying sputum as a diagnostic tool in pneumonia. Chest. 2002;121:1486–1492
  9. Garcia-Vazquez E, Marcos MA, Mensa J, et al. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch Intern Med. 2004;164:1807–1811
  10. Vergis EN, Yu VL. New directions for future studies of community-acquired pneumonia: optimizing impact on patient care. Eur J Clin Microbiol Infect Dis. 1999;18:847–851
  11. Plouffe JF, McNally C, File TM. Value of noninvasive studies in community-acquired pneumonia. Infect Dis Clin North Am. 1998;12:689–691
  12. Dean NC. Use of prognostic scoring and outcome assessment tools in the admission decision for community-acquired pneumonia. Clin Chest Med. 1999;20:521–529
  13. Menendez R, Torres A, Zalacaín R, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004;59:960–965
  14. Carratalà J, Fernandez-Sabe N, Ortega L, et al. Outpatient care compared with hospitalization for community-acquired pneumonia. A randomized trial in low-risk patients. Ann Intern Med. 2005;142:165–172
  15. Wattanathum A, Chaoprasong Ch, Nunthapisud P, et al. Community-acquired pneumonia in Southeast Asia. The microbial differences between ambulatory and hospitalized patients. Chest. 2003;123:1512–1519
  16. Gutiérrez F, Masiá M, Rodríguez JC, et al. Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain. Clin Microbiol Infect. 2005;11:788–800
  17. Ortega L, Sierra M, Dominguez J, et al. Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia. Scand J Infect Dis. 2005;37:657–663
  18. Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J. 2002;20:20–27
  19. Garbino J, Gerbase M, Wunderli W, et al. Respiratory viruses and severe lower respiratory tract complications in hospitalized patients. Chest. 2004;125:1033–1039
  20. De Roux A, Marcos M, García E, et al. Viral community-acquired pneumonia in nonimmunocompromised adults. Chest. 2004;125:1343–1351
  21. Nauffal D, Menendez R, Morales P, et al. Community viral pneumonia in the adult population: a prospective multicenter study of 62 cases. The Pneumonia study group of the community of Valencia. article in Spanish. Rev Clin Esp. 1990;187:229–232
  22. Lagerström F, Bader M, Foldevi M, Fredlund H, Nordin-Olsson I, Holmberg H. Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Örebro, Sweden. Clin Microbiol Infect. 2003;9:645–652
  23. Liolios L, Jenney A, Spelman D, Kotsimbos T, Catton M, Wesselingh S. Comparison of a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens. J Clin Microbiol. 2001;39:2779–2783
  24. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–351
  25. Creer DD, Dilworth JP, Gillespie SH, et al. Aetiological role of viral and bacterial infections in adult lower respiratory tract infection (LRTI) in primary care. Thorax. 2006;61:75–79
  26. Sobradillo V, Ansola P, Baranda F, Corral C. Q fever pneumonia: a review of 164 community-acquired cases in the Basque country. Eur Respir J. 1989;2:263–266
  27. Dupuis G, Petite J, Peter O, Vouilloz M. An important outbreak of human Q fever in a Swiss alpine valley. Int J Epidemiol. 1987;16:282–287
  28. Stout JE, Yu VL. Legionellosis. N Engl J Med. 1997;337:682–687
  29. Torres A, Dorca J, Zalacain R, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease. A Spanish multicentre study. Am J Respir Crit Care Med. 1996;154:1456–1461
  30. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730–1754
  31. Lim WS, Macfarlane JT, Boswell TC, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax. 2001;56:296–301
  32. de Roux A, Ewig S, Garcia E, et al. Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J. 2006;27:794–800
  33. Gutierrez F, Masia M, Rodriguez JC, et al. Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome. Eur J Clin Microbiol Infect Dis. 2005;24:377–383
  34. Briones ML, Blanquer J, Ferrando D, Blasco ML, Gimeno C, Marin J. Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults. Clin Vaccine Immunol. 2006;13:1092–1097

PII: S0954-6111(07)00194-1

doi: 10.1016/j.rmed.2007.05.007

Respiratory Medicine
Volume 101, Issue 10 , Pages 2168-2175 , October 2007

Article Tools